{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T21:06:21.850947+00:00","company":{"ticker":"NHTC","cik":912061,"company_name":"NATURAL HEALTH TRENDS CORP"},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"055e719105a657e157cc942595509f0537416213","cik":912061,"ticker":"NHTC","company_name":"NATURAL HEALTH TRENDS CORP","filed_at":"2026-04-29T23:59:59+00:00","payload":{"eps_text":"$0.02 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$154,000","period_text":"the quarter ended March 31, 2026","report_date":"2026-04-29","result_type":"reported_results","revenue_text":"$9.2 million"},"claim":"NATURAL HEALTH TRENDS CORP reported the quarter ended March 31, 2026 results: revenue $9.2 million, net income $154,000, EPS $0.02 per diluted share.","evidence_excerpt":"First Quarter 2026 Financial Highlights • Revenue of $9.2 million decreased 6% compared to $9.7 million in the fourth quarter of 2025 and declined 14% compared to $10.7 million in the first quarter of 2025. • Operating loss was $474,000 compared to $635,000 in the fourth quarter of 2025 and $345,000 in the first quarter of 2025. • Net loss was $154 ,000, or $0.02 per diluted share, compared to $588,000, or $0.05 per diluted share, in the fourth quarter of 2025 and net income of $122,000, or $0.01 per diluted share, in the first quarter of 2025.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-013743","anchor_url":"https://secwatch.observer/filing/0001437749-26-013743#claim-055e719105a657e157cc942595509f0537416213","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/912061/000143774926013743/0001437749-26-013743-index.htm"},{"fact_type":"material_agreement","fact_key":"256eae9e701c73e286e137b9616ee662d8949f29","cik":912061,"ticker":"NHTC","company_name":"NATURAL HEALTH TRENDS CORP","filed_at":"2026-02-17T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Repurchase Agreement","agreement_type":"equity_purchase","counterparty":"George K. Broady 2012 Irrevocable Trust and the Eleanor Jane Broady 2012 Irrevocable Trust","effective_date":"2026-02-17","item_codes_triggered":["1.01"],"value_text":"approximately $5.9 million"},"claim":"NATURAL HEALTH TRENDS CORP entered into Repurchase Agreement with George K. Broady 2012 Irrevocable Trust and the Eleanor Jane Broady 2012 Irrevocable Trust valued at approximately $5.9 million (effective 2026-02-17).","evidence_excerpt":"On February 17, 2026, Natural Health Trends Corp. (the “Company”) entered into a share repurchase agreement (the “Repurchase Agreement”) with the George K. Broady 2012 Irrevocable Trust and the Eleanor Jane Broady 2012 Irrevocable Trust (collectively, the “Sellers”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-004352","anchor_url":"https://secwatch.observer/filing/0001437749-26-004352#claim-256eae9e701c73e286e137b9616ee662d8949f29","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/912061/000143774926004352/0001437749-26-004352-index.htm"},{"fact_type":"executive_change","fact_key":"ffa2025dd1","cik":912061,"ticker":"NHTC","company_name":"NATURAL HEALTH TRENDS CORP","filed_at":"2024-07-31T23:59:59+00:00","payload":{"action":"elected","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-29","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Lucy Nduati was elected as director at NATURAL HEALTH TRENDS CORP.","evidence_excerpt":"On July 29, 2024, the Board of Directors of the Company, upon the recommendation of the Company's Nominating and Corporate Governance Committee, expanded the size of the Board of Directors to five (5) members and elected Lucy Nduati as a director to fill the newly created directorship.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-023999","anchor_url":"https://secwatch.observer/filing/0001437749-24-023999#claim-ffa2025dd1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/912061/000143774924023999/0001437749-24-023999-index.htm"},{"fact_type":"earnings_release","fact_key":"b1904ac0fcaf4200be9308f8f808ed4bf5139b84","cik":912061,"ticker":"NHTC","company_name":"NATURAL HEALTH TRENDS CORP","filed_at":"2024-05-01T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$188,000, or $0.02 per diluted share","period_text":"the quarter ended March 31, 2024","report_date":"2024-05-01","result_type":"reported_results","revenue_text":"$11.0 million"},"claim":"NATURAL HEALTH TRENDS CORP reported the quarter ended March 31, 2024 results: revenue $11.0 million, net income $188,000, or $0.02 per diluted share.","evidence_excerpt":"of life” products under the NHT Global brand, today announced its financial results for the quarter ended March 31, 2024 . First Quarter 2024 Financial Highlights • Revenue of $11.0 million decreased 8% compared to $11.9 million in the first quarter of 2023 . The decrease was entirely due to changes in the differences in deferred revenue between the two periods.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-014080","anchor_url":"https://secwatch.observer/filing/0001437749-24-014080#claim-b1904ac0fcaf4200be9308f8f808ed4bf5139b84","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/912061/000143774924014080/0001437749-24-014080-index.htm"}]}